Phase I/II Double Blind Randomized Trial of Lenalidomide/Dexamethasone/Anakinra vs. Lenalidomide/Dexamethasone/Placebo in Patients With Early Stage Multiple Myeloma and High Plasma Cell Growth Rate
Phase of Trial: Phase I/II
Latest Information Update: 23 May 2018
At a glance
- Drugs Anakinra (Primary) ; Dexamethasone; Lenalidomide
- Indications Multiple myeloma
- Focus Adverse reactions; Therapeutic Use
- 15 May 2018 Status changed from recruiting to suspended as per study design
- 16 Nov 2017 Status changed from active, no longer recruiting to recruiting.
- 28 Jun 2017 Status changed from suspended to active, no longer recruiting.